276 related articles for article (PubMed ID: 18486285)
1. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
Lambert PH; Laurent PE
Vaccine; 2008 Jun; 26(26):3197-208. PubMed ID: 18486285
[TBL] [Abstract][Full Text] [Related]
2. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.
Nicolas JF; Guy B
Expert Rev Vaccines; 2008 Oct; 7(8):1201-14. PubMed ID: 18844594
[TBL] [Abstract][Full Text] [Related]
3. Devices for intradermal vaccination.
Kis EE; Winter G; Myschik J
Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
[TBL] [Abstract][Full Text] [Related]
4. Implication of nanoparticles/microparticles in mucosal vaccine delivery.
Vyas SP; Gupta PN
Expert Rev Vaccines; 2007 Jun; 6(3):401-18. PubMed ID: 17542755
[TBL] [Abstract][Full Text] [Related]
5. Needle-free vaccine delivery.
Giudice EL; Campbell JD
Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
[TBL] [Abstract][Full Text] [Related]
6. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
[TBL] [Abstract][Full Text] [Related]
7. [Oral vaccination and vaccine-entrapped microparticle delivery system].
Li FQ; Fei YB; Su H; Hu JH
Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
[TBL] [Abstract][Full Text] [Related]
8. Oral vaccine delivery: can it protect against non-mucosal pathogens?
Wang L; Coppel RL
Expert Rev Vaccines; 2008 Aug; 7(6):729-38. PubMed ID: 18665772
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
10. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.
Laurent PE; Bonnet S; Alchas P; Regolini P; Mikszta JA; Pettis R; Harvey NG
Vaccine; 2007 Dec; 25(52):8833-42. PubMed ID: 18023942
[TBL] [Abstract][Full Text] [Related]
12. Intradermal delivery for vaccine dose sparing: overview of current issues.
Zehrung D; Jarrahian C; Wales A
Vaccine; 2013 Jul; 31(34):3392-5. PubMed ID: 23176978
[TBL] [Abstract][Full Text] [Related]
13. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
Herzog C
Expert Rev Vaccines; 2014 Mar; 13(3):399-415. PubMed ID: 24512188
[TBL] [Abstract][Full Text] [Related]
14. Intradermal delivery of vaccines: potential benefits and current challenges.
Hickling JK; Jones KR; Friede M; Zehrung D; Chen D; Kristensen D
Bull World Health Organ; 2011 Mar; 89(3):221-6. PubMed ID: 21379418
[TBL] [Abstract][Full Text] [Related]
15. Intradermal immunization: an alternative route for vaccine administration. Articles as per sessions meeting report.
Picot V
Vaccine; 2008 Dec; 26 Suppl 9():S1-5. PubMed ID: 19268138
[No Abstract] [Full Text] [Related]
16. Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes.
Tsals I; Jarrahian C; Snyder FE; Saganic L; Saxon E; Zehrung D; Zimmerman G; Papania M; Klaff L
Vaccine; 2015 Sep; 33(37):4705-11. PubMed ID: 25964169
[TBL] [Abstract][Full Text] [Related]
17. Opportunities and challenges in vaccine delivery.
Carstens MG
Eur J Pharm Sci; 2009 Mar; 36(4-5):605-8. PubMed ID: 19063966
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
[TBL] [Abstract][Full Text] [Related]
19. Recent insights into cutaneous immunization: How to vaccinate via the skin.
Engelke L; Winter G; Hook S; Engert J
Vaccine; 2015 Sep; 33(37):4663-74. PubMed ID: 26006087
[TBL] [Abstract][Full Text] [Related]
20. Intradermal powder immunization with protein-containing vaccines.
Weissmueller NT; Schiffter HA; Pollard AJ
Expert Rev Vaccines; 2013 Jun; 12(6):687-702. PubMed ID: 23750797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
